A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia
Clinical trial NCT07619118 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07619118
- Sponsor
- AstraZeneca
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-15
- Primary completion
- 2027-05-28
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.